ArticleBrazilian journal of otorhinolaryngology
Audiometric evaluation of bone conduction thresholds reveals subclinical sensorineural hearing loss in patients with ankylosing spondylitis and psoriatic arthritis.
Article in Brazilian journal of otorhinolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hearing impairment in patients with axial spondyloarthritis: association with chronic inflammatory burden and neurobiological proteins.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveHearing Loss (HL) has been increasingly recognized as a potential extra-articular manifestation in systemic autoimmune diseases, yet data on audiological involvement in Spondyloarthritis (SpA), particularly Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA), remain limited. This study aimed to evaluate bone conduction hearing thresholds in patients with AS and PsA compared to Healthy Controls (HC) and to investigate associations with clinical and inflammatory parameters.
methodsIn this retrospective cross-sectional study, Pure Tone Audiometry (PTA) was used to assess bone conduction thresholds in 53 patients with AS, 53 with PsA, and 53 age- and sex-matched HCs. Associations between hearing thresholds and clinical features, disease activity indices, comorbidities, and HLA-B27 status were analyzed.
resultsMean bone conduction thresholds were significantly higher in AS (14.85 ± 3.78 dB) and PsA (15.53 ± 9.37 dB) groups compared to controls (9.23 ± 3.42 dB, p < 0.001). In the overall cohort, hearing thresholds correlated with patient global assessment (rho = 0.307, p = 0.001), physician global assessment (rho = 0.280, p = 0.002), BASDAI (rho = 0.222, p = 0.017), ASQoL (rho = 0.304, p = 0.001), disease onset age (rho = 0.216, p = 0.020), and BMI (rho = 0.246, p = 0.008). Within disease groups, no consistent correlation was found between hearing thresholds and conventional disease activity scores.
conclusionSubclinical sensorineural hearing impairment may be an underrecognized extra-articular feature of AS and PsA. Routine audiological assessment should be considered, especially in patients with long-standing disease, metabolic comorbidities, or subjective auditory complaints. LEVEL OF EVIDENCE: 3:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.